Developing and commercializing solutions for treating mental health problems
Mydecine Innovations is an emerging biotech and life sciences company. They're dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality. Moreover, the company’s world-renowned medical and scientific advisory board is building out a robust R&D pipeline of nature-sourced psychedelic-assisted therapeutics, novel compounds, therapy protocols, and unique delivery systems.
Most of the compounds found in mushrooms are not psychedelic, but still provide benefits to us. For example, the trend of using Lion's Mane mushrooms to improve focus and learning is becoming increasingly popular. Turkey Tail mushrooms have also been shown to help support the body's immune system. Today both of these mushrooms are being grown, processed and sold in numerous forms. This can include capsules, chocolate bars, teas, and more. Lion's Mane and Turkey Tail are just two examples of many rare and exotic species that Mydecine™️ plans to explore and discover their many incredible wellness benefits. These unique and incredible fungi can provide a new and diverse path to healthy living.
Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility. The facitlity has the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds. Further, this is done with full government approval through Health Canada. Mydecine also operates out of a state-of-the-art mycology lab in Denver, CO to focus on genetic research for scaling commercial cultivation of rare (non-psychedelic) medicinal mushrooms.
"We can take it from the cultivation stage through the full R&D stage and then we have the licencing capabilities to export that globally, " says Director and CEO and Co-Founder, Joshua Bartch.
For more information on Mydecine Innovations Group (NEO: MYCO, OTC: MYCOF) please click the request investor info button.